Searched for
MEDICINES VITAMINS AND VACCINES
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- In the shadow of COVID, health officials fight panic over Hantavirus outbreakA hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...
- Govt may mandate QR codes on vaccines, key drugs to curb counterfeitsThe government is considering mandating bar codes or QR codes on labels for vaccines, antimicrobials, narcotics, psychotropic substances, a...
- Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
- Can taking vitamins and supplements help you recover from Covid? Study illustrates some challengesSupplements can cause harm in the form of adverse effects, drug interactions and expense.
- Dealing with asthma amid the pandemic isn’t easy. Upping vegetable intake, adding milk & eggs to your plate might helpIt is estimated that India has almost 2 crore asthma patients.
- Drugmaker GSK cuts ties with Russia government over Ukraine crisisThe Ukraine crisis is in its second month and the West has tightened restrictions on Moscow, but healthcare companies have not pulled out o...
- Pakistan lifts ban on import of Indian drugsET has learnt that Pakistan government has lifted the ban on import of medicines and raw material from India to ensure there is no shortage...
- Panic buying of drugs down since mid-AprilSales of anti-infective medicines in the April 1-22 period eased to 62% from levels seen from March 1to 22. While sales of antidiabetes dru...
- NPPA hikes 21 formulations’ prices by 50%The National Pharmaceuticals Pricing Authority (NPPA) invoked paragraph 19 of the Drug Prices Control Order to grant a 50% increase in the ...
- Soon, chemists may face legal action for failing to comply with storage normsThe Centre is planning to introduce stringent guidelines on distribution practices for drug companies.
Load More
